Park, Jae H.
Memorial Sloan Kettering Cancer Center · Weill Cornell Medicine
7 papers on CoChatORCID 0000-0002-2903-5130
Most cited papers
- Verified
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
Lee, D. W., Santomasso, B. D., Locke, F. L., Ghobadi, A., Turtle, C. J., Brudno, J. N., Maus, M. V., Park, J. H., Mead, E., Pavletic, S., et al. (2019) · Biology of Blood and Marrow Transplantation
CAR-T cell therapy researchCancer Immunotherapy and Biomarkers
Cited by 3,675
- Verified
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Park, J. H., Rivière, I., Gonen, M., Wang, X., Sénéchal, B., Curran, K. J., Sauter, C., Wang, Y., Santomasso, B., Mead, E., et al. (2018) · New England Journal of Medicine
CAR-T cell therapy researchAcute Lymphoblastic Leukemia research
Cited by 2,688
- Verified
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia
Brentjens, R. J., Davila, M. L., Riviere, I., Park, J., Wang, X., Cowell, L. G., Bartido, S., Stefanski, J., Taylor, C., Olszewska, M., et al. (2013) · Science Translational Medicine
CAR-T cell therapy researchAcute Lymphoblastic Leukemia research
Cited by 2,063
- Verified
Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
Santomasso, B. D., Park, J. H., Salloum, D., Riviere, I., Flynn, J., Mead, E., Halton, E., Wang, X., Senechal, B., Purdon, T., et al. (2018) · Cancer Discovery
CAR-T cell therapy researchAcute Lymphoblastic Leukemia research
Cited by 942
- Verified
Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
Smith, M., Dai, A., Ghilardi, G., Amelsberg, K. V., Devlin, S. M., Pajarillo, R., Slingerland, J. B., Beghi, S., Herrera, P. S., Giardina, P., et al. (2022) · Nature Medicine
CAR-T cell therapy researchGut microbiota and health
Cited by 349
- Verified
Phase I First-in-Class Trial of MCARH109, a G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D) Targeted CAR T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma
Mailankody, S., Diamonte, C., Fitzgerald, L., Kane, P., Wang, X., Sikder, D. S., Senechal, B., Bermudez, V. P., Frias, D., Morgan, J., et al. (2021) · Blood
CAR-T cell therapy researchMultiple Myeloma Research and Treatments
Cited by 30
- Verified
Akathisia: a life-threatening side effect of a common medication
Cheng, H. M., Park, J. H., & Hernstadt, D. (2013) · BMJ Case Reports
Schizophrenia research and treatmentElectroconvulsive Therapy Studies
Cited by 16
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free